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Abstract
A group of 101 women, aged 40-65 years consisted of 48 premenopausal subjects and 53 postmenopausal ones living in Daegu and Gyeongbuk 
area in Korea were evaluated with their general characteristics, lifestyle factors, nutrient and phytoestrogen intakes, blood and urinary indices concerning
antioxidant status and bone metabolism. Body mass index (BMI), waist hip ratio (WHR) and systolic blood pressure (SBP) of the postmenopausal
women were significantly higher (23.8, 0.86, and 126.9 mmHg, respectively) than those of the premenopausal women (22.6, 0.82, and 115.9 mmHg;
respectively). Nutrient intakes of the postmenopausal and premenopausal groups were not different except lower fat intake and higher dietary fiber
and iron intakes in the postmenopausal group. Daily total phytoestrogen intake was significantly higher in the postmenopausal group (48.54 mg)
than the premenopausal (31.41 mg) and was resulted mostly from higher intakes of daidzein and genistein from soy and soy products (45.42 mg
vs 28.91 mg). Serum genistein level and excretion of enterolactone, major lignan metabolite, were not very different between the two groups. Serum
retinal and α- tocopherol levels were higher in the postmenopausal group but TBARS levels were not different between the two groups. Serum
osteocalcin (7.18 ng/mL) and urinary deoxypyridinoline (7.15 nmol/mmol creatinine), in the postmenopausal group were significantly higher than
those in the premenopausal group (4.80 ng/mL, 5.95 nmol/mmol creatinine). Urinary excretion of enterolactone was positively correlated with serum 
osetocalcin in premenopausal women and serum genistein negatively correlated with the urinary DPD in postmenopausal women. Dietary phytoestrogen
intake was negatively correlated with serum level of TBARS in all subjects. It is concluded that the effect of total phytoestrogen intake is beneficial
on body antioxidant status in all middle-aged women regardless of menopause but the effect on bone metabolism appears different by the type
of the phytoestrogen and the menopausal state.
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Introduction10)
As our country is entering into the aging society, the aging 
of women is more distinct and the average life span was 75.1 
years in males and 81.9 years in females according to the 2005 
data of the Korea National Statistical Office (Korea National 
Statistics, 2005). The population of menopausal women has been 
increased as the life after menopause becomes about 30 years 
if the average age of menopause is around 50. Menopause has 
become a serious health problem for women over 50 because 
it can increase the incidence of osteoporosis, cardiovascular 
diseases and senile dementia due to the loss of ovarian follicle 
and the lack of estrogen. Hormone replacement therapy (HRT) 
including synthetic estrogens has been used to reduce these 
postmenopausal problems. However, recent studies (Writing 
group for the WHI investigators, 2002) have reported that HRT 
on the contrary increased not only breast cancer and venous 
thromboembolism but also coronary artery disease and stroke. 
Thus, alternative methods for HRT have been searched in several 
ways and studies on phytoestrogens, which are found in foods 
and plants and have similar structures and functions as estrogen, 
have been actively performed. Phytoestrogens include isoflavone, 
lignan and coumestan, and recently added stillbene (Cornwell 
et al., 2004). Among these, soy isoflavone has been well known 
for its reported effects on suppressing breast cancer, preventing 
arteriosclerosis and osteoporosis, alleviating menopausal symp-
toms and improving cognitive function (Cornwell et al., 2004). 
Lignans, which are plenty in grains, fruits, vegetables, and seeds, 
have been reported to be effective in the prevention of breast 
cancer (Boccardo et al., 2004), uterine cancer, prostate cancer 
(Lin et al., 2001) and osteoporosis (Ward et al., 2001). Although 
the intake of coumestans is low in the country, it should be noted 
that coumestrol contained in soybean sprouts, which is commonly 
eaten in Korea, is one of representing coumestans. Also, 
coumestrol has weak estrogen functions (Whitten et al., 2002), 
with reported effects of preventing bone resorption in ovariec-
tomized rats (Saga et al., 2003) and preventing cancers and 
cardiovascular diseases (Adlercruts & Mazur, 1997). Besides the 
estrogenic and antiestrogenic activities (Zava and Duwe 1997, 
the phytoestrogens have antioxidant activity due to polyphenolic 
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Table 1. Grouping of phytoestrogen concentrations into score categories* 
Phytoestrogen, mg/100 g Phytoestrogen score, mg/100g
0
0.00001-0.00099, trace
0.001-0.0099
0.01-0.099
0.1-0.99
1-9.99
10 and over
0
0.0005
0.005
0.05
0.5
5
50
*  Boker  LK  et  al.,  2002 
structure (Murkies et al., 1998). The antioxidant activities were 
demonstrated  in vitro and in vivo (Tikkanen et al., 1998) and 
are regarded as the additional function for the prevention of 
various chronic diseases (Cornwell et al., 2004). 
Such functions of phytoestrogen are widely known but the 
current status of phytoestrogen intake has been studied mainly 
for soy isoflavone both in domestic and foreign studies (Cui et 
al., 2006; Kim & Khil, 2007; Kirk et al., 1999; Lee et al., 2000; 
Maskarine  et al., 1998). Recently in foreign countries, the 
database for phytoestrogen contents in many foodstuff has been 
established (De Klein et al., 2001; Reinli & Block, 1996; 
USDA-IOWA database; Valsta et al., 2003). However, the 
content may be extremely small depending on the kind of foods 
and thus its precision can become problematic. To make up for 
such aspect, Boker et al. (2002) has recently introduced the 
concept of phytoestrogen score. By using this, the reports for 
total phytoestrogen intake have been increased in other countries 
and also retrospective study results using the existing data have 
been reported (De Klein et al., 2001a; De Klein et al., 2001b). 
However, we have not tried such effort for the investigation of 
total phyetoestrogen in the country.
Therefore, this study was performed to investigate the phytoes-
trogen intakes of Korean women before and after menopause 
by using our phytoestrogen database for 120 kinds of domestic 
foods developed with reference to the database established in 
other countries. In addition, the serum and urine levels of some 
phytroestrogen and its metabolite as well as status of vitamins 
A and E and lipid peroxidation and bone markers were also 
measured to evaluate their interrelations with regard to meno-
pause.
Subjects and Methods 
Subjects 
Subjects were selected by 48 pre-menopausal women and 53 
post-menopausal women aged between 40 and 65, who visited 
the public health center located in Chilgok-gun, Gyeongsangbuk- 
do during the months of June and July in 2004. Age, lifestyle 
factors, gynecological and obstetric history of subjects were 
investigated through the general survey questionnaire. Anthro-
pometry and blood pressure were directly measured by a trained 
researcher. Fasting blood samples were taken early in the morn-
ing for serum preparation and urine samples were taken at the 
same time and added with a little toluene, and both samples were 
stored at -70℃ until analyzed. 
Dietary intake by 24-hour recall
Nutrients intake was investigated by 24-hour recall method and 
a total of 3 days including 2 weekdays and 1 weekend day were 
chosen for recording the type and amount of foods eaten. These 
were then used for calculating nutrient intake using CAN-pro 
(version 2.0). Food consumption was recorded by a trained 
researcher through direct interview, and real-sized food models 
and pictures were used to help subjects recall the amounts of 
foods (The Korean Dietetic Association, 1999). 
Phytoestrogen intake by food frequency 
The phytoestrogen database for 120 types of foods was estab-
lished on the basis of the preliminary study on types of foods 
preferred by subjects and with reference to the existing data 
(Boker  et al., 2002; De Klein et al., 2001; Lee et al., 2000; 
Reinli & Block, 1996; Valsta et al., 2003; USDA-IOWA 
database). The composition of 120 kinds of foods were 18 grains 
& grain products, 46 beans & bean products, 16 fruits, 23 
vegetables, 10 Kimchis, 3 teas and coffees, 3 alcoholic beverages, 
and 1 other. Phytoestrogens in the database include isoflvones 
such as daidzein, genistein, formononetin, and biochain A, and 
coumestans such as coumesterol, and lignans such as mataires-
inol, secoisolariciresino, eterolactone and enterodiol. The intake 
of phytoestrogen was obtained from food frequency survey 
questionnaire. The questionnaire presented 1 serving size and 
actual consumption per a food item and the frequency was 
divided into a total of 11 frequencies including seldom eaten 
(①), a few times in a year (② record the number), once or 2~3 
times a month (③, ④) 1, 2, 3~4, 5~6 times a week (⑤,  ⑥, 
⑦, ⑧), 1, 2, 3 times a day (⑨, ⑩, ⑪) (Jang, 2007).  Phytoes-
trogen intake was calculated according to the method of Boker 
et al. (2002). The phytoestrogen concentration per 100 g of each 
food was categorized into 7 levels of scores as shown in Table 
1. Thus, if phytoestrogen score (mg/100 g) is known from the 
range of phytoestrogen contained in 100 g of a certain food, 
then the phytoestrogen content was calculated by multiplying the 
amount per serving and daily frequency to that score. 
Phytoestrogen contents calculated after the frequency survey 
were added to estimate the daily consumption for 120 food items 
in the survey questionnaire.   
Biochemical analysis 
Serum genistein was quantified by using TR-FIA (time- 
resolved fluoroimmunoassay) with Labmaster (Turku, Finland) 
genistein Kit (1212-2003) and urinary enterolactone was quan-
tified in the same manner with   Labmaster enterolactone Kit Jeong-Hee Jang et al. 307
Table 2. General characteristics of the study subjects
Variables Premenopausal women
(n=48)
Premenopausal women
(n=53) Significance
Age (yrs) 45.6 ± 4.9
(40~51)
55.0 ± 5.2
(41~57)
P＜0.1
6)
Menopause 
(yrs)
－ 50.0 ± 4.9 －
Menarche 
(yrs)
15.3 ± 1.5 16.3 ± 1.8 p＜0.001
6)
Height (cm) 156.9 ± 4.5 155.9 ± 4.6 NS
7)
Weight (kg) 55.6 ± 6.0 58.0 ± 7.3 NS
BMI (kg/m
2)
1) 22.6 ± 2.7 23.8 ± 2.5 p＜0.05
6)
＜18.5 － 1(1.9) NS
18.5～22.9 29(60.4)
5) 20(37.7)
23.0～24.9 11(22.9) 14(26.4)
＞25.0 8(16.7) 18(34.0)
WHR
2) 0.82 ± 0.05 0.86 ± 0.06 p＜0.001
6)
＜0.85 35(72.9) 23(43.4) p＜0.01
8)
≥0.85 13(27.1) 30(56.6)
SBP (mmHg)
3) 115.9 ± 15.0 126.9 ± 20.3 p＜0.01
6)
DBP (mmHg)
4) 72.7 ± 9.3 76.2 ± 15.4 NS
1) BMI  :
  Body  mass  index
2) WHR  :  Waist  hip  circumference  ratio 
3) SBP  :  Systolic  blood  pressure 
4) DBP  :  Diastolic  blood  pressure 
5) N  (%) 
6) N S  :  N o t  s i g n i f ic a n t 
7) Significantly  different  by  t-test 
8) Significantly  different  by  X
2-test
Table 3. Daily nutrient intakes of the study subjects 
Variables
Premenopausal 
women
(n=48)
Postmenopausal 
women
(n=53)
Significance
2)
Energy (kcal) 1,537.2 ± 331.9
1) 1,509.7 ± 321.7 NS
3)
Carbohydrate (g) 241.9 ± 58.8 253.0 ± 55.2 NS
Fat (g) 37.4 ± 14.1 31.4 ± 10.2 p<0.05
Protein (g) 54.5 ± 15.0 53.9 ± 14.4 NS
Dietary Fiber (g) 12.0 ± 4.1 14.0 ± 5.2 P<0.05
Vitamin A (μg RE) 598.3 ± 300.1 682.3 ± 367.2 NS
Carotene (μg) 2438 ± 1556 2594 ± 1314 NS
Vitamin E (mg α-TE) 9.4 ± 4.6 9.9 ± 3.9 NS
Vitamin C (mg) 67.3 ± 24.0 73.1 ± 33.3 NS
Vitamin B1 (mg) 1.3 ± 0.6 1.4 ± 0.7 NS
Vitamin B2 (mg) 1.1 ± 0.4 1.1 ± 0.5 NS
Niacin (mg) 2.0 ± 3.8 12.4 ± 3.1 NS
Vitamin B6 (mg) 1.5 ± 0.5 1.7 ± 0.5 NS
Folate (μg) 186.4 ± 55.9 195.2 ± 62.3 NS
Calcium (mg) 454.3 ± 166.5 466.8 ± 158.8 NS
Phosphorus (mg) 807.4 ± 218.8 828.8 ± 222.9 NS
Na (mg) 3,381.1 ± 1,057.1 3,217.8 ± 1,081.4 NS
Iron (mg) 10.3 ± 3.1 11.6 ± 3.0 p<0.05
Zinc (mg) 6.6 ± 1.6 6.9 ± 1.7 NS
Cholesterol (mg) 193.9 ± 112.4 160.4 ± 75.7 NS
1) Mean ± SD
2) Significantly  different  by t - test 
3) NS  :  Not  significantly  different 
(1212-2001). 
Serum retinol and α-tocopherol were quantified at the same 
time according to the method of Bieri (Bieri et al., 1979) by 
using HPLC (column, Bondapak C18, mobile phase, methanol/ 
H2O (97/3)). At this time, the internal standards used were retinyl 
acetate and tocopheryl acetate, respectively. Serum lipid pero-
xides were measured by using Yagi method (Yagi, 1976) for 
the measurement of TBARS, the substances that reacted with 
thiobarbituric acid (TBA), and 1,1,3,3-tetramethoxypropane was 
used as a standard. 
Serum osteocalcin and urinary deoxypyridinoline (DPD) were 
measured in Samkwang Reference Laboratories (Seoul, Korea) 
by IRMA method with the Osteocalcin-IRMA kit from Bio-
sourse
TM, and the urinary deoxypyridinoline (DPD) excretion was 
measured by using Gamma-BCT DPD flow Diagram
R kit from 
Immuno Diagnostic System
R and with a 1470-Wizard γ-Counter. 
Statistical analysis 
All data obtained from this study were analyzed by SAS 
program to produce the mean and standard deviation. General 
characteristics of subjects were analyzed using χ
2-test and the 
significance of difference between premenopausal and postmeno-
pausal women was verified using t-test at p<0.05. 
Results 
General characteristics of the subjects 
The significance between anthropometry and maternal factors 
of pre- and post-menopausal women is shown in Table 2. Total 
number of subjects was 101, including 48 pre-menopausal and 
53 post-menopausal women. The average age of pre-menopausal 
women was 45.6 years and that of post-menopausal women was 
55.0 years, and the average age of menopause was 50 years. 
Two of the post-menopausal women were at the age of 41 and 
45 because they had undergone ovariectomy. The age of men-
arche was one year higher in post-menopausal women group. 
There was no significant differences in average height and weight 
between two groups but the body mass index (BMI) was 22.6 
in pre-menopausal group and 23.8 in post-menopausal group, 
which was significantly higher (p<0.05). This is because the 
number of subjects with the BMI of 18.5~22.9 was 29 in pre- 
menopausal women, which was more than half of the group, 
while it was only 38% in post-menopausal group, which had 
more in the overweight range of 23.0~24.9 and the obese range 
of over 25.0. Waist-hip ratio (WHR) was 0.82 in pre-menopausal 
group and 0.86 in post-menopausal group, which was signi-
ficantly higher. Blood pressure was in the normal range in both 
groups but the systolic blood pressure of post-menopausal group 
was higher compared to the pre-menopausal group. 308 phytoestrogen intake by Korean women
Table 4. Daily intakes of various dietary phytoestrogens of the subjects
Phytoestrogen
Mean intake score, mg/day
Significance Premenopausal 
women
(n=46)
Postmenopausal 
women
(n=53)
Daidzein 
Genistein 
Formononetin
Biochanin A 
Total isoflavones 
14.43±10.06
1)
14.47±10.09
0.008±0.007
0.0006±0.0010
28.91±20.14
22.61±10.96
22.80±10.90
0.006±0.006
0.0011±0.0020
45.42±21.85
 p<0.0001
2)
p<0.0001
NS
3)
NS
p<0.0001
Coumesterol 
Total coumestans 
1.04±0.91
1.04±0.91
1.32±1.39
1.32±1.39
NS
NS
Matairesinol 
Secoisolariciresinol 
Enterolactone 
Enterodiol 
Total lignans 
0.07±0.82
0.41±0.20
0.48±0.26
0.50±0.21
1.46±0.29
0.13±0.19
0.45±0.31
0.58±0.42
0.64±0.53
1.80±0.53
p<0.05
NS
p<0.05
p<0.01
p<0.01
Total phytoestrogen  31.41±21.63 48.54±23.77 p<0.0001
1) Values  are  mean±SD 
2) Significantly  different  by t - test 
3) N S  :  N o t  s ig n if i c a n t l y  d i f f e r e n t 
Table 5. Serum genistein levels and urinary enterolactone excretion of the 
subjects 
Variables
Premenopausal 
women
(n=48)
Postmenopausal 
women
(n=53)
Significance
2)
Serum genistein 
(nmol/L)
n=42 n=45
NS
3)
120.5±117.4
1) 169.3±142.1
Urine enterolactone
(nmol/mmol creatinine)
n=38 n=38
NS
228.0±265.5 173.1±116.6
1)  Values  are  mean±SD
2)  Significantly  different  by t - test 
3)  NS  :  Not  significantly  different 
Table 6. Serum levels of retinol, α-tocopherol and TBARS of the subjects 
Variables
Premenopausal 
women
(n=48)
Postmenopausal 
women
(n=53)
Significance
2)
Retinol (μg/ml) 0.41±0.08
1) 0.46±0.10 p<0.05
α-Tocopherol (μg/ml) 9.34±2.07 10.76±2.65 p<0.01
α-Tocopherol 
(μg/mg cholesterol)
5.35±0.94  5.64±1.06 NS
3)
TBARS (MDA nmol/ml) 1.48±0.49  1.65±0.62 NS
3)
1)  Values  are  mean±SD
2)  Significantly  different  by t - test 
3)  NS  :  Not  significantly  different 
Daily nutrient intakes 
The results for the average daily nutrient intakes from 3 days 
of food consumption survey using 24-hour recall method are 
shown in Table 3. There was no significant differences in nutrient 
intakes between two groups, except fat and iron. Energy intakes 
were similar in pre-menopausal group and post-menopausal 
group as 1,537 kcal and 1,510 kcal, respectively, but pre-menop-
ausal women consumed more fat as 37 g compared to 31 g in 
post-menopausal women. Dietary fiber and iron intakes were 12.0 
g and 10.3 mg in pre-menopausal women, respectively, and 14.0 
g and 11.6 mg in post-menopausal women, which were signi-
ficantly higher. The average intakes of vitamins and minerals 
examined in the present study were not significantly different 
between groups but tended to be higher in post-menopausal 
women compared to pre-menopausal women. 
Daily phytoestrogen intakes and body status 
Daily phytoestrogen intakes of subjects were calculated using 
the food frequency survey for 120 foods as shown in Table 4. 
Isoflavone was 90~93% of ingested phytoestrogen and was 28.91 
mg in pre-menopausal women and 45.42 mg in post-menopausal 
women. Almost all of these isoflavones were made of diadzein 
and genistein and each of which took half of the total isoflavone 
intake, suggesting that these are most important sources of 
soybean-derived phytoestrogen. Coumesterol is a single com-
ponent but was about 1 mg/day, which was 3% of the total 
phytoestrogen intakes, and lignan intake was 1.5~1.8 g, which 
was 4% of the total phytoestrogen. Phytoestrogen intake between 
pre- and post-menopausal women showed that the intake of 
post-menopausal women was greater by 50% than that of pre- 
menopausal women. This increment was due to the increased 
intake of isoflavone. However, coumesterol intake tended to be 
higher in post-menopausal women and most lignan types were 
higher in post-menopausal women. Total phytoestrogen intake 
in diet was significantly higher in the postmenopausal group 
(48.54 mg) than in the premenopausal group (31.41 mg).
The kinds of phytoestrogen ingested by subjects were several, 
but in this study, only serum genistein level and urinary excretion 
of enterolactone, which is one of major metabolites of lignans, 
were measured for the content of these substances in the body. 
As presented in Table 5, the average concentration of serum 
genistein in pre-menopausal women was 120.5 nmol/L while that 
in post-menopausal women was 169.3 nmol/L, which was slightly 
higher. Urinary enterolactone excretion was 173.1 nmol/L in 
post-menopausal women, while 228.0 nmol/L in pre-menopausal 
women. 
Body antioxidant status and bone marker levels 
Serum retinol, α-tocopherol and lipid peroxide measured as 
thiobarbituric acid reactive substances (TBARS) were measured 
from the study subjects and the results are shown in Table 6. 
Serum retinol was 0.41 μg/ml in pre-menopausal women while 
0.46 μg/ml in post-menopausal women, which was significantly 
higher, and also the concentration of α-tocopherol was higher 
in post-menopausal women. However, there was no difference 
between two groups when serum α-tocopherol was compared to 
serum cholesterol (α-tocopherol μg/mg chlesterol). The average 
serum TBARS was 1.48 nmol/ml in pre-menopausal women and 
1.65 nmol/ml in post-menopausal women, which was slightly 
higher but not significant. 
Serum osteocalcin level, which is a bone formation index, and 
urinary deoxypyridinoline (DPD), which is a bone resorption 
index, are shown in Table 7. Serum osteocalcin in most subjects Jeong-Hee Jang et al. 309
Table 7. Serum Osteocalcin and urinary deoxypyridinoline (DPD) excretion of 
the subjects
Variables
Premenopausal 
women
(n=48)
Postmenopausal 
women
(n=53)
Significance
Osteocalcin (ng/ml) 4.80±2.16
1) 7.18±3.05 p<0.0001
3)
1.02-15.1
(Normal range)
>15.1
48(100.0)
2)
-
52(98.1)
1(1.9)
NS
5)
Deoxypyridinoline 
(nmol/mmol creatinine)
5.95±2.44 7.15±2.39 p<0.05
3)
2.5-6.5
(Normal range)
>6.5
35(72.9) 
13(27.1)
21(39.6)
32(60.4)
p<0.001
4)
1)  Values  are  mean±SD 
2) N ( % )  
3)  Significantly  different  by  t-test 
4)  Significantly  different  by  X
2-test 
5)  NS:  Not  significantly  different 
Table 8. Correlation coefficients between dietary phytoestrogen intake, serum 
osteocalcin, urine deoxypyridinoline (DPD) and serum osteocalcin, urine DPD 
and serum TBARS levels of the pre- and post-menopausal women
Subjects Serum
Osteocalcin Urine DPD Serum
TBARS
Premenopausal Dietary  phytoestrogen 
intake
-0.2143 0.1734 -0.5912**
*
women Serum genistein 0.0904 -0.0092 -0.2515
Urine enterolactone 0.4797** 0.1547 0.0075
Postmenopausal Dietary phytoestrogen 
intake
-0.1057 0.3341 -0.4649**
women Serum genistein -0.1383 -0.3957* -0.0657
Urine enterolactone -0.2149 -0.0461 -0.1358
*p ＜0.05
** p＜0.01
*** p＜0.005
was within the normal range, 1.02~15.1 ng/ml, but the average 
level was 4.8 ng/ml in pre-menopausal women and high as 7.18 
ng/ml in post-menopausal women. The average urinary DPD 
concentration was 5.95 nmol/mmol creatinine in pre-menopausal 
women, while 7.15 nmol/mmol creatinine in post-menopausal 
women, which was significantly higher. Also, the number of 
subjects outside the normal range of 2.5~6.5 nmol/mmol 
creatinine was 13 (27.1%) in pre-menopausal women, but 31 
(60.4%) in post-menopausal women, showing a significant 
difference between two groups. The correlations among bone 
marker, serum TBARS value, total phytoestrogen intake, serum 
genistein and urinary DPD levels in pre-menopausal and 
post-menopausal women are presented in Table 8. While there 
was a positive correlation between urine enterolactone and serum 
osteocalcin level in pre-menopausal women, no correlation was 
found in post-menopausal women. Serum genistein level showed 
a negative correlation with urine DPD level in post-menopausal 
women. Serum TBARS values showed higher negative correla-
tions with dietary phytoestrogen intakes in both groups. 
Discussion
Physical conditions of subjects in this study showed higher 
BMI, WHR and blood pressure in post-menopausal women when 
compared to pre-menopausal women, which were consistent with 
other studies (Haarbo et al., 1991; Wing et al., 1991) and 
confirmed higher chances for chronic diseases. Such recognition 
is considered as a factor for reducing fat intake from the meals 
in post-menopausal women. However, when the nutrient intakes 
of subjects in this study were compared to the Dietary Reference 
Intakes for Koreans (Korean Nutrition Society, 2005), most 
subjects were in the range under the recommended intake (RI) 
but close to the estimated average requirement (EAR). But, 
dietary fiber was only 55% of adequate intake (AI) in pre- 
menopausal women and 64% in post-menopausal women, 
suggesting a considerably low intake level. Calcium intake was 
454 mg in pre-menopausal women, which was 65% of RI (700 
mg), but post-menopausal women maintained the same level. 
Actually, the RI of women over 50 was increased to 800 mg 
and thus the lack became larger compared to pre-menopausal 
state. Therefore, it seems necessary to actively induce dietary 
changes to increase the calcium intake in relation to osteoporosis, 
which is the most serious problem after menopause. 
As the importance of phytoestrogen for the prevention of 
chronic diseases such as osteoporosis in women is highlighted, 
many studies on its intake, metabolism and functions have been 
performed. Soybean isoflavone is the first to be known among 
phytoestrogens but the degree of its intakes have shown great 
differences depending on races and regions. A study on the 
isoflavone intake among races in Hawaii using a frequency 
survey for soybean food intake showed that the average intakes 
of Chinese and Japanese people were 10~20 mg but those of 
Caucasian and Philippine was only 5 mg (Maskarine et al., 1998). 
The study for the isoflavone intake of Dutch women using a 
food frequency questionnaire (FFQ) for 227 foods developed to 
investigate total phytoestrogen intake including isoflavone and 
lignan showed the result of 0.88 mg (Boker et al., 2002), and 
the result calculated by using the Framingham study data was 
0.78 mg (De Klein et al., 2001a), and the intake of Americans 
except Asians in the year of 2000 was calculated as 2.87 mg 
(Horn-Ross  et al., 2000). These results were lower than those 
from the studies performed before 2000 (Adlercreuts et al., 1991; 
Kirk et al., 1999; Maskarine et al., 1998) and considered as the 
differences among subjects but may possibly be the differences 
of investigation methods. Phytoestrogen intake studies in Korea 
have been performed mainly on soy isoflavone, and its average 
intake was in the range of 15 mg to 48 mg with differences 
(Choi  et al., 2005; Cui et al., 2006; Kim & Khil 2007; Kim 
& Kwon, 2001; Lee et al., 2000), which were considered as 
differences due to subjects and regions. However, a common 
aspect found in any survey study is great individual differences 
ranging from 0 to 200 mg. In this study, the isoflavone intake 
calculated by using a recently developed phytoestrogen score was 310 phytoestrogen intake by Korean women
in the range of 29~45 mg, which was rather higher compared 
to the average values calculated from frequency surveys for 
soybean food intake in Korea. Diadzein and genistein took almost 
100% of total isoflavone and formononectin and biochanin A 
were negligible, which is different from the results of foreign 
studies. The most noticeable result in this study was that the 
isoflavone intake of post-menopausal women was increased by 
50% compared to that of pre-menopausal women, which was 
similar to the result from the study by Cui et al. (2006) in which 
menopausal women with osteoporosis showed higher isoflavone 
intake compared to women in the control group (48.56 mg vs 
29.19 mg). It is considered that this result was caused by 
increased intakes of soybean foods such as tofu (~20 g/d), bean 
paste (10~15 g/d) and other bean containing foods (~5~15 g/d) 
due to increased information on health and nutrition of 
menopausal women in these days. Foods containing coumestan 
among phytoestrogens are very limited and one foreign study 
showed its amount as 0.2~1.7. μg/day (De Klein et al., 2001a) 
and up to 0.2 mg/day when considering Asian population (Boker 
et al., 2002). Coumesterol, a representing form of coumestan, 
is plenty in one of our common food, soy bean sprout (~1 
mg/100g ; phytoestroen score 5; Relini & Block, 1996) and thus 
expected to have higher intake in Korean people, which was 
confirmed in this study for the first time. Coumesterol in mung 
bean sprout, which is largely consumed in China and Japan, was 
not detectable unlike soy bean sprout (Relini & Block, 1996), 
suggesting that the coumesterol intake in Koreans may be higher 
among Asians. It is meaningful that the lignan intake in daily 
meals of Koreans was first reported in this study. Lignan intake 
has been reported as 0.20~1.11 mg/day in Europe (Boker et al., 
2002; Kikkinen et al., 2003) and in the USA (De Klein et al., 
2001a). The result of this study showed that the lignan intake 
of Korean women was higher than that of Western people. This 
is considered as reasonable in view of the fact that the major 
sources of lignan are grains and seeds such as sesame seed. 
However, when considering the fact that all domestic foods were 
not included in the database used in this study, it is possible 
that lignan intake was underestimated. Under the same condition, 
all kinds of lignan intakes were significantly higher in post- 
menopausal women compared to pre-menopausal women, 
reflecting the health-oriented multi-grain intake of this group.  
Phytoestrogens in foods are mainly in the form of glycosides 
containing sugars and changed into aglycone and absorbed in 
the digestive process. Also, considerable amount of these agly-
cones can be fermented by colonic bacteria and isoflavone is 
converted into O-desmethylangolensin and equol, and lignan is 
converted into enterolactone and enterodiol, and then absorbed 
and some are excreted in feces (Lampe, 2003). As the accuracy 
of phytoestrogen intake can be problematic, efforts have been 
made to measure these metabolites in blood and urine in addition 
to phytoestrogen itself to understand the degree of its intake. 
Most studies (Adlercreutz et al., 1991; Hutchins et al., 1995; 
Lampe, 2003) reported that the intake and urinary excretion of 
isoflavone or its metabolites were more strongly correlated with 
their dietary intakes than those of lignans. But one Finnish study 
(Kikkinen et al., 2003) supported the strong correlation of lignan 
intakes and serum enterolactone. In this study, phytoestrogen and 
metabolites content in the body were investigated in a very 
limited way and such correlation was not shown although serum 
genistein appeared to be higher in post-menopausal women 
whose phytoestrgen intake was higher compared to pre-meno-
pausal women. The increase in urinary DPD as well as serum 
osteocalcin in post-menopausal women was consistent with other 
study results (Choi et al., 2000; Kawana et al., 1994). The result 
in this study showed lower urinary DPD as serum genistein 
became higher in post-menopausal women. It is interpreted as 
an important role of suppressing bone resorption by increasing 
soybean isoflavone intake in daily meals. However, the excretion 
of enterolactone, unlike lignan intake, was not high in post- 
menopausal women, suggesting that the lignan intake was 
possibly underestimated as mentioned above. Thus, further 
research is needed to figure out this result. Urinary enterolactone 
excretion in Korean menopausal women reported by Kim et al. 
(2002) was 180~360 μmol/day and that from this study was 170 
~228 μmol/L. The 24-hour urine content was not measured in 
this study but when considering the daily urine volume as 1.0~1.5 
L, the urinary enterolactone result of this study and that of Kim 
et al. (2002) were in the same range. It was reported in these 
results that subjects with osteopenia or osteoporosis showed 
lower urinary enterolactone than normal subjects, but the cause 
was not clear because lignan intake of subjects was not reported. 
In this study, the osteocalcin content, a bone formation marker, 
was increased in post-menopausal women, which is thought as 
increased overall bone turnover due to accelerated bone loss 
(Peichl  et al., 1998). This basic physiological change after 
menopause seems to have much higher impact on urinary DPD 
and serum osteocalcin levels than the dietary phytoestrogn, 
resulting in different correlations between these bone markers 
and the phytoestrogen intake in pre- and post-menopausal 
women. On the other hand, it is very important that serum lipid 
peroxide was decreased as dietary phytoestrogen intake became 
higher in all subjects. Considering that most of the phytoestrogens 
are polyphenolic compounds and possess the antioxidant capacity 
(Tikkanen  et al., 1998, Hutchins et al., 2005), this result was 
not unexpected. However, the higher phytroestrogen intake 
appears to have significance for post-menopausal women whose 
serum TBARS level were not reduced despite of higher serum 
α-tocopherol level compared with pre-menopausal women to 
maintain proper body oxidant/antioxidant status. 
It is concluded that the dietary phytoestrogen is beneficial by 
decreasing oxidative stress in all middle-aged women regardless 
of menopause and can help to prevent the incidence of several 
chronic diseases that are markedly increased after menopause. 
But the effect of phytoestrogen on bone metabolism and health 
appears different by the type of the phytoestrogen and the 
menopausal state and is to be further investigated in the future.Jeong-Hee Jang et al. 311
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